As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Computational Biology Market: By Application: Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Others; By Services; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Computational Biology Market Outlook

The global computational biology market stood at a value of more than USD 3.5 billion in 2021. The market is further expected to grow at a CAGR of 22.5% in the forecast period of 2022-2027 to attain a value of over USD 11.8 billion by 2027.

 

Growing Application in Cellular and Biological Simulation Segment, owing to its Reliable Statistical Analysis, to Bolster the Growth of the Computational Biology Industry

Based on application, the cellular and biological simulation segment accounts for a significant share in the market and is anticipated to witness a considerable growth in the forecast period. The growth of this segment is driven by the growing importance of computational genomics, which is used to help sequence the human genome, create accurate models of the human brain, and assist in modelling biological systems.

 

Global Computational Biology Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Computational genomics offers a reliable computational and statistical analysis to decipher biology from genome sequences and related data, which is likely to be a major driving factor driving the segment growth.

 

North America Accounts for a Significant Share in the Market

The computational biology industry in North America is driven by the growing investments towards the development of efficient design and modelling-related computational tools in the region to assess the complexity of biological systems. Over the forecast period, the rising government funding towards academic and biological research studies in countries like the United States and Canada is likely to propel the growth of the computational biology industry. The market in the region will further be aided by the growing penetration of advanced digital solutions and high-performance computation tools, coupled with the growing R&D across the region.

 

Computational Biology: Industry Definition and Segmentation

Computational biology is defined as a field of science that involves the collection, storage, organisation, and analysis of a large amount of biological, medical, and health-related data with the help of computers, databases, applied mathematics, statistics, and others. It involves the development and application of mathematical modelling, computational simulation techniques, and data-analytical methods to the study of biological systems.

Based on application, the market is segmented into:

  • Cellular and Biological Simulation
    • Computational Genomics
      • Databases
      • Infrastructure (Hardware)
      • Analysis Software and Services
    • Computational Proteomics
    • Pharmacogenomics
    • Others
  • Drug Discovery and Disease Modelling
    • Target Identification
    • Target Validation
    • Lead Discovery
    • Lead Optimisation
  • Preclinical Drug Development 
    • Pharmacokinetics
    • Pharmacodynamics
  • Clinical Trials
    • Phase I
    • Phase II
    • Phase III
  • Human Body Simulation Software

On the basis of services, the industry is divided into:

  • In-House
  • Contract

The major end uses of computational biology include:

  • Academics
  • Industry
  • Commercial

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Application in Various End Use Sectors to Boost the Growth of the Computational Biology Industry

The global computational biology industry is driven by its growing demand in various end use sectors, including academics and research studies. The computational approaches help enhance the management of a large volume of data during clinical trials and allow for the efficient utilisation of biological data to develop algorithms. The rapid development of molecular biology and genetic engineering tools has been contributing to the market growth significantly. Over the forecast period, the growing application of computational biology in various commercial and third-party services for carrying out drug discovery processes is likely to accelerate the market growth. Additionally, the acceleration in research and development activities to further drug discovery and disease modelling, especially after the COVID-19 outbreak, is expected to favour the market growth.

 

Key Industry Players in the Global Computational Biology Market

The report gives a detailed analysis of the following key players in the global computational biology market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Chemical Computing Group ULC
  • Dassault Systèmes S.E.
  • Certara, Inc.
  • Leadscope Inc.
  • Compugen Ltd.
  • Genedata AG
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, Services, End Use, Region
Breakup by Application Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software
Breakup by Services In-House, Contract
Breakup by End Use Academics, Industry, Commercial
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Chemical Computing Group ULC, Dassault Systèmes S.E., Certara, Inc., Leadscope Inc., Compugen Ltd., Genedata AG, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Computational Biology Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Computational Biology Historical Market (2017-2021) 
    8.3    Global Computational Biology Market Forecast (2022-2027)
    8.4    Global Computational Biology Market by Application
        8.4.1    Cellular and Biological Simulation
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Technology
                8.4.1.4.1    Computational Genomics
                    8.4.1.4.1.1    Market Share
                    8.4.1.4.1.2    Historical Trend (2017-2021)
                    8.4.1.4.1.3    Forecast Trend (2022-2027)
                    8.4.1.4.1.4    Breakup by Type
                        8.4.1.4.1.4.1    Databases
                        8.4.1.4.1.4.2    Infrastructure (Hardware)
                        8.4.1.4.1.4.3    Analysis Software and Services
                8.4.1.4.2    Computational Proteomics
                    8.4.1.4.2.1    Market Share
                    8.4.1.4.2.2    Historical Trend (2017-2021)
                    8.4.1.4.2.3    Forecast Trend (2022-2027
                8.4.1.4.3    Pharmacogenomics
                    8.4.1.4.3.1    Market Share
                    8.4.1.4.3.2    Historical Trend (2017-2021)
                    8.4.1.4.3.3    Forecast Trend (2022-2027)
                8.4.1.4.4    Others
        8.4.2    Drug Discovery and Disease Modelling
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Process
                8.4.2.4.1    Target Identification
                    8.4.2.4.1.1    Market Share
                    8.4.2.4.1.2    Historical Trend (2017-2021)
                    8.4.2.4.1.3    Forecast Trend (2022-2027)
                8.4.2.4.2    Target Validation
                    8.4.2.4.2.1    Market Share
                    8.4.2.4.2.2    Historical Trend (2017-2021)
                    8.4.2.4.2.3    Forecast Trend (2022-2027)
                8.4.2.4.3    Lead Discovery 
                    8.4.2.4.3.1    Market Share
                    8.4.2.4.3.2    Historical Trend (2017-2021)
                    8.4.2.4.3.3    Forecast Trend (2022-2027)
                8.4.2.4.4    Lead Optimisation
                    8.4.2.4.4.1    Market Share
                    8.4.2.4.4.2    Historical Trend (2017-2021)
                    8.4.2.4.4.3    Forecast Trend (2022-2027)
        8.4.3    Preclinical Drug Development
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
            8.4.3.4    Breakup by Mechanism 
                8.4.3.4.1    Pharmacokinetics
                    8.4.3.4.1.1    Market Share
                    8.4.3.4.1.2    Historical Trend (2017-2021)
                    8.4.3.4.1.3    Forecast Trend (2022-2027)
                8.4.3.4.2    Pharmacodynamics
                    8.4.3.4.2.1    Market Share
                    8.4.3.4.2.2    Historical Trend (2017-2021)
                    8.4.3.4.2.3    Forecast Trend (2022-2027)
        8.4.4    Clinical Trials
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
            8.4.4.4    Breakup by Phase
                8.4.4.4.1    Phase I
                    8.4.4.4.1.1    Market Share
                    8.4.4.4.1.2    Historical Trend (2017-2021)
                    8.4.4.4.1.3    Forecast Trend (2022-2027)
                8.4.4.4.2    Phase II
                    8.4.4.4.2.1    Market Share
                    8.4.4.4.2.2    Historical Trend (2017-2021)
                    8.4.4.4.2.3    Forecast Trend (2022-2027)
                8.4.4.4.3    Phase III
                    8.4.4.4.3.1    Market Share
                    8.4.4.4.3.2    Historical Trend (2017-2021)
                    8.4.4.4.3.3    Forecast Trend (2022-2027)
        8.4.5    Human Body Simulation Software
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
    8.5    Global Computational Biology Market by Services
        8.5.1    In-House
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Contract
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Computational Biology Market by End Use
        8.6.1    Academics
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Industry
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Commercial
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global Computational Biology Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Chemical Computing Group ULC
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Dassault Systèmes S.E.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Certara, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Leadscope Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Compugen Ltd.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Genedata AG
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Computational Biology Market: Key Industry Highlights, 2017 and 2027
2.    Global Computational Biology Historical Market: Breakup by Application (USD Billion), 2017-2021
3.    Global Computational Biology Market Forecast: Breakup by Application (USD Billion), 2022-2027
4.    Global Computational Biology Historical Market: Breakup by Services (USD Billion), 2017-2021
5.    Global Computational Biology Market Forecast: Breakup by Services (USD Billion), 2022-2027
6.    Global Computational Biology Historical Market: Breakup by End Use (USD Billion), 2017-2021
7.    Global Computational Biology Market Forecast: Breakup by End Use (USD Billion), 2022-2027
8.    Global Computational Biology Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Computational Biology Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Computational Biology Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Computational Biology Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Computational Biology Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Computational Biology Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Computational Biology Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Computational Biology Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Computational Biology Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Computational Biology Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Computational Biology Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Computational Biology Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Computational Biology Market Structure

Key Questions Answered in the Report

In 2021, the global computational biology market attained a value of more than USD 3.5 billion.

The market is estimated to grow at a CAGR of 22.5% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach over USD 11.8 billion by 2027.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the industry, such as the rising applications of computational biology in various end use sectors, the growing demand for efficient database management and computational tools for clinical trials and drug discovery processes, and growing digitalisation, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing technological advancements in the biotechnology sector, along with the increasing penetration of digital solutions.

Cellular and biological simulation, drug discovery and disease modelling, preclinical drug development, clinical trials, and human body simulation software are the major applications of computational biology.

In-house and contract are the different services in the computational biology market.

Academics, industry, and commercial are the significant end uses of computational biology.

The major players in the industry are Chemical Computing Group ULC, Dassault Systèmes S.E., Certara, Inc., Leadscope Inc., Compugen Ltd., and Genedata AG, among others.

Analyst Review

The global computational biology market attained a value of more than USD 3.5 billion in 2021, driven by the growing technological advancements, rapid development of molecular biology, and increasing application of computational biology in various end use sectors. Aided by the growing R&D activities aimed towards drug discovery, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 22.5%. The market is projected to reach over USD 11.8 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on application, the market is divided into cellular and biological simulation, drug discovery and disease modelling, preclinical drug development, clinical trials, and human body simulation software. On the basis of service, the market is segmented into in-house and contract. The significant end uses of the product include academics, industry, and commercial. The major regional markets for computational biology are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Chemical Computing Group ULC, Dassault Systèmes S.E., Certara, Inc., Leadscope Inc., Compugen Ltd., and Genedata AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER